Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9074 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.897 |
High Similarity |
NPD7808 |
Phase 3 |
0.8909 |
High Similarity |
NPD7251 |
Discontinued |
0.8848 |
High Similarity |
NPD6797 |
Phase 2 |
0.8675 |
High Similarity |
NPD7472 |
Approved |
0.8634 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8614 |
High Similarity |
NPD7054 |
Approved |
0.8581 |
High Similarity |
NPD6799 |
Approved |
0.8562 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD7075 |
Discontinued |
0.8509 |
High Similarity |
NPD3817 |
Phase 2 |
0.85 |
High Similarity |
NPD6801 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8418 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8408 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8261 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8171 |
Intermediate Similarity |
NPD5402 |
Approved |
0.811 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8107 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8098 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8063 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7874 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7831 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD919 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7744 |
Intermediate Similarity |
NPD920 |
Approved |
0.7744 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD8313 |
Approved |
0.774 |
Intermediate Similarity |
NPD8312 |
Approved |
0.773 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7683 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7679 |
Intermediate Similarity |
NPD2801 |
Approved |
0.764 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7622 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD1511 |
Approved |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7458 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7442 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7409 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7362 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3887 |
Approved |
0.733 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7697 |
Approved |
0.733 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD7698 |
Approved |
0.732 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7243 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7216 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7202 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7125 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7088 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7052 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7052 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7051 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7031 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7011 |
Intermediate Similarity |
NPD37 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7 |
Intermediate Similarity |
NPD2403 |
Approved |
0.6989 |
Remote Similarity |
NPD4965 |
Approved |
0.6989 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD4966 |
Approved |
0.6988 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6987 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6985 |
Remote Similarity |
NPD7801 |
Approved |
0.6975 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6952 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6951 |
Remote Similarity |
NPD6651 |
Approved |
0.6932 |
Remote Similarity |
NPD5353 |
Approved |
0.6927 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD2354 |
Approved |
0.6923 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6911 |
Remote Similarity |
NPD6534 |
Approved |
0.6911 |
Remote Similarity |
NPD6535 |
Approved |
0.691 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6905 |
Remote Similarity |
NPD2800 |
Approved |
0.6901 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD6585 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD447 |
Suspended |
0.689 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6886 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6879 |
Remote Similarity |
NPD1091 |
Approved |
0.6867 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD2897 |
Discontinued |
0.6837 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD4288 |
Approved |
0.6828 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6190 |
Approved |
0.6823 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6823 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD6844 |
Discontinued |
0.679 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6765 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6761 |
Remote Similarity |
NPD6386 |
Approved |
0.6761 |
Remote Similarity |
NPD6385 |
Approved |
0.6758 |
Remote Similarity |
NPD5242 |
Approved |
0.6752 |
Remote Similarity |
NPD17 |
Approved |
0.6751 |
Remote Similarity |
NPD5005 |
Approved |
0.6751
|
Remote Similarity |
NPD5006 |
Approved |